Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

26.01
Delayed Data
As of 12:57pm ET
 +0.09 / +0.35%
Today’s Change
20.07
Today|||52-Week Range
42.48
-8.06%
Year-to-Date

Today’s Trading

Previous close25.92
Today’s open25.91
Day’s range25.43 - 26.65
Volume109,925
Average volume (3 months)325,559
Market cap$857.9M
Dividend yield--
Data as of 12:57pm ET, 05/06/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+68.75%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio93.5
Price/Sales11.37
Price/Book6.96

Competitors

 Today’s
change
Today’s
% change
FWPForward Pharma A/S-0.08-0.44%
MACKMerrimack Pharmaceut...-0.15-2.26%
TBPHTheravance Biopharma...+0.18+0.98%
FOLDAmicus Therapeutics ...-0.23-3.52%
Data as of 1:16pm ET, 05/06/2016

Financials

Last reporting dateMay 5, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs